Arvinas (ARVN) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
How The Arvinas (ARVN) Story Is Evolving As 2026 Neurology Catalysts Approach [Yahoo! Finance]
Arvinas (ARVN) had its price target raised by Citigroup Inc. from $18.00 to $21.00. They now have a "buy" rating on the stock.
Arvinas (ARVN) had its price target raised by BTIG Research from $14.00 to $16.00. They now have a "buy" rating on the stock.
Arvinas (ARVN) was given a new $10.00 price target by Truist Financial Corporation.